⬡ ORION BIOTECH DILIGENCE

Source-linked biotech diligence,ready for review.

ORION connects companies, drug assets, clinical trials, regulatory events, and market context into a reviewable diligence brief.

Review a sample diligence brief

ENTITY-VERIFIED · SOURCE-LINKED · CHANGE-TRACKED · EXPORT-READY · HONEST ABOUT MISSING DATA

Search → Verify entity → Review evidence → Compare competitors → Track changes → Export memo

VERIFIED RESEARCH QUEUE

Daily Radar

At most three source-verifiable targets. No placeholder events.

ORION Labs · Signal Feed prototypeDEMO · COLLAPSED

Signal Feed

SAMPLE DATA · UI PROTOTYPE

A preview of what a continuous signal stream could look like on ORION. The cards below are fixed samples for layout review only — no change detection, monitoring job, or data source is connected yet.

⚠ DEMO SIGNAL HIGH

Moderna MRNA

mRNA-4157 / V940

Phase 2 endpoint update detected

Changes to the primary or secondary endpoint may alter how trial results are interpreted, and could affect the timing or probability of later-stage development.

Sample timestamp — 2h ago

⚠ DEMO SIGNAL MEDIUM

CRISPR Therapeutics CRSP

Pipeline gene-editing candidate (sample)

Trial recruitment status changed

A shift in recruitment status (e.g. active → paused, or completed enrollment) can move an expected data-readout date earlier or later, which may change how near-term a catalyst appears.

Sample timestamp — 6h ago

⚠ DEMO SIGNAL INFO

Vertex Pharmaceuticals VRTX

Pipeline asset (sample)

FDA review date updated

A target action date moving by a few weeks is common administrative variance and is usually not, by itself, a signal about the likely outcome of the review.

Sample timestamp — 1d ago

⚠ DEMO SIGNAL MEDIUM

Pfizer PFE

Sector peer — same drug class (sample)

Competitor entered Phase 3

A competitor advancing to Phase 3 in the same drug class can change the competitive landscape and timing pressure for other companies developing similar therapies.

Sample timestamp — 1d ago

QUICK:

PRIMARY

ClinicalTrials.gov

CURATED

FDA Coverage

MIXED

Source Freshness

Daily Radar

A daily queue of no more than three source-verified targets. Empty days remain empty.

Loading market data…

Loading FDA calendar…

Loading news…

Loading verified reports…

Experimental. Outputs are research support, not validated investment recommendations. Coverage may be incomplete; verify linked evidence before use.

Loading predictions…

Loading accuracy…

Command Center

Biotech Intelligence Before the Market Reacts — AI report, financials, catalysts, news, and risk in one screen.

Alerts

PDUFA dates, clinical trial status changes, and price moves — rule-based, disclosed, per company on your watchlist.

Asset Workbench

Source-recorded competitive pipelines and explicit, user-supplied rNPV assumptions. ORION never inserts hidden valuation defaults.

Experimental. Outputs are research support, not validated investment recommendations. Coverage may be incomplete; verify linked evidence before use.

Portfolio Intelligence

Upload positions, review catalyst concentration, and separate recorded risk signals from unavailable coverage.

Organization & Audit

Server-enforced seats, roles, invitations, workspaces, and an append-only administrative audit log.

Watchtower

Continuous monitoring across your watchlist — every detected change evidenced, scored for materiality, and traced to the ORION score it affects.

Thesis Ledger

A permanent, versioned record of every investment thesis ORION has held for a company — nothing is ever overwritten or hidden, right or wrong.

Impact Chain

How one event propagates through ORION's reasoning — each step evidenced, confidence-rated, and never presented as more certain than the data supports.

Research preferences

Each preference is stored independently on this device.